Date of birth: 16/01/1944

BIOGRAPHY

In 1986, French oncologist Jean-Louis Misset led the phase I trial of oxaliplatin at Paul Brousse Hospital, Paris. The study showed that while renal toxicity was low, nausea and vomiting were significant.

Misset graduated in medicine from the University of Paris in 1972, and later trained in oncology with Georges Mathé at Paul Brousse Hospital. Since 2001, he has been professor of oncology at Paris Diderot University. He has worked on the clinical development of drugs such as topotecan, docetaxel and trastuzumab, including a prospective study of doxorubicin in breast cancer.

Personal experience of the pleasures of choral singing led Misset to set up choral singing workshops for oncology patients.